alexa Outliers: The Case for Individualized Therapy

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

Global Summit on Pharmacology and Therapeutics

Vienna, Austria

European Summit on Pharmacology and Toxicology

Vienna, Austria

Advancement in Drug Discovery

New York, USA
Outliers: The Case for Individualized Therapy

An outlier is a scientific term to describe things or phenomena that lie outside normal experience. In pharmacokinetics this would be a parameter such as drug clearance or half-life that has a value that is much different from the average. Patients with pharmacokinetic parameters that are outliers are often the most difficult to manage. Identifying the reasons for being an outlier has always been a goal in the field of pharmacokinetics/pharmacodynamics.


Citation: Slaughter RL (2012) Outliers: The Case for Individualized Therapy. Adv Pharmacoepidem Drug Safety S1:e001. doi: 10.4172/2167-1052.S1-e001

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger